Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Clin Pharmacol. 2020 Feb 12;60(6):744–750. doi: 10.1002/jcph.1575

Table 2.

Pharmacokinetic Parameter Estimates for UDCA Obtained Using Noncompartmental Analysis

Subject ID Dose (mg/ kg) tmax (h) Cmax (ng/mL) Cmin (ng/mL) AUC(0-tau) (μg • h/mL) Clss/F (mL/min/kg) Vz/F (mL/kg) Half-life (t1/2) (h) Accum. index Fluctuation %

1 30 2.5 5441 613 21.0 9.0 1556 2.0 1.07 184
2 50 1 10 377 2603 38.4 7.7 1438 2.1 1.08 162
3 50 1 5166 902 19.5 16.6 4445 3.1 1.20 175
4 50 2 11 523 780 28.0 10.2 845 1.0 1.00 307
5 50 2.9 11 237 934 23.5 15.2 1466 1.1 1.01 351
Mean 1.9 8749 1166 27.4 11.8 1950 1.9 1.1 236
Standard deviation 0.8 2840 727 7.1 3.5 1273 0.8 0.1 77.6

AUC(0-tau), area under the concentration-time curve from time 0 to infinity, CLss/F, apparent clearance at steady state, Cmax, maximum plasma concentration; Cmin, minimum plasma concentration; Tmax, time at maximum concentration; Vz/F, apparent volume of distribution.